Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas A. Kelly
Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab : One-Year Outcome in the EPILOG Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Stent Parameters Predict Major Adverse Clinical Events and the Response to Platelet Glycoprotein IIb/IIIa Blockade: Findings of the ESPRIT Trial
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment
Heart
Platelet Inhibition With an Antibody to Glycoprotein IIb/IIIa
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Glycoprotein IIb/IIIa Induced Coronary Thrombolysis
Heart
A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Clinical Significance of Thrombocytopenia During a Non ST-Elevation Acute Coronary Syndrome : The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Experience
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes
Circulation
Cardiovascular Medicine
Physiology
Cardiology
